Microbix Biosystems (TSX:MBX) Short-Term Debt : C$0.11 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Short-Term Debt?

Microbix Biosystems's Short-Term Debt for the quarter that ended in Mar. 2024 was C$0.11 Mil.

Microbix Biosystems's quarterly Short-Term Debt stayed the same from Sep. 2023 (C$0.11 Mil) to Dec. 2023 (C$0.11 Mil) and stayed the same from Dec. 2023 (C$0.11 Mil) to Mar. 2024 (C$0.11 Mil).

Microbix Biosystems's annual Short-Term Debt declined from Sep. 2021 (C$2.45 Mil) to Sep. 2022 (C$0.11 Mil) but then stayed the same from Sep. 2022 (C$0.11 Mil) to Sep. 2023 (C$0.11 Mil).

Microbix Biosystems Short-Term Debt Historical Data

The historical data trend for Microbix Biosystems's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Short-Term Debt Chart

Microbix Biosystems Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Short-Term Debt

Get a 7-Day Free Trial

2.58

1.13

2.45

0.11

Microbix Biosystems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															0.11	0.11	0.11	0.11	0.11

Microbix Biosystems Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Microbix Biosystems Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems (TSX:MBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Executives

James Stuart Currie

Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines